PF-03654746
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-03654746, covering 2014-06-04 to 2016-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD). [Phase 2]